Constellation Investments’s Pfizer PFE Stock Holding History

Constellation Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.02M	Buy	143,038 +316	+0.2%	+$9.03K	0.74%	26
2015 Q4	$4.37M	Buy	142,722 +2,740	+2%	+$86.2K	0.82%	23
2015 Q3	$4.17M	Buy	139,982 +527	+0.4%	+$16.9K	0.86%	20
2015 Q2	$4.44M	Buy	139,455 +2,635	+2%	+$85.9K	0.85%	20
2015 Q1	$4.52M	Buy	136,820 +2,108	+2%	+$67K	0.86%	22
2014 Q4	$3.98M	Buy	134,712 +5,059	+4%	+$145K	0.81%	23
2014 Q3	$3.64M	Buy	129,653 +1,476	+1%	+$41.4K	0.81%	23
2014 Q2	$3.61M	Buy	128,177 +2,108	+2%	+$60.1K	0.83%	22
2014 Q1	$3.84M	Buy	126,069 +632	+0.5%	+$18.8K	0.93%	21
2013 Q4	$3.65M	Buy	125,437 +6,641	+6%	+$193K	0.93%	20
2013 Q3	$3.24M	Buy	118,796 +6,007	+5%	+$163K	0.99%	21
2013 Q2	$3M	Buy	+112,789	New	+$3.12M	1.04%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Constellation Investments's PFE Position: Q1 2016 in Review

Constellation Investments increased its Pfizer (PFE) stake by 0.22% in Q1 2016, buying an estimated $9.03K and bringing the position to 143,038 shares worth $4.02M. The position accounts for 0.74% of the portfolio, ranked #26.

Constellation Investments first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.52M in Q1 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Constellation Investments held 143,038 shares of Pfizer worth $4.02M as of Q1 2016.
Constellation Investments bought 316 Pfizer shares in Q1 2016, an estimated $9.03K.
Pfizer made up 0.74% of Constellation Investments's portfolio in Q1 2016, its #26 holding.
Constellation Investments first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Pfizer position peaked at $4.52M in Q1 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.